Staging and surgery for non-small cell lung cancer (NSCLC).
Despite current advances in diagnosis, staging, and treatment, carcinoma of the lung remains the leading cause of death from cancer in both men and women. Non-small cell lung cancer represents approximately 80% of all new lung cancer cases; however, only one-third of these cases will undergo surgical resection for tumor control. This article reviews the evaluation, latest revisions in staging, and surgical management of non-small cell lung cancer.
Division of Cardiothoracic Surgery, University of Texas Medical Branch, Galveston 77555-0528, USA.
S K
SK
Alpard
J B
JB
Zwischenberger
D000465:Algorithms; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology* / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000601:surgery*; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging / Q000379:methods*; D010166:Palliative Care; D011013:Pneumonectomy; D013510:Pulmonary Surgical Procedures